Neoadjuvant intracarotid chemotherapy for treatment of advanced adenocystic carcinoma of the lacrimal gland

Archives of Ophthalmology

Volumn 116, Issue 3, 1998, Pages 315-321

  Meldrum, Melissa L ^a,b   Tse, David T ^a   Benedetto, Pasquale ^a  

^a Departments of Ophthalmology

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LACRIMAL GLAND TUMOR; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031891503     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.3.315     Document Type: Article

References (42)

1. Zimmerman LE, Sanders TE, Ackerman LV. Epithelial tumors of the lacrimal gland: prognostic and therapeutic significance of histologie types. Int OphthalmolClin. 1962;2:337-367.
2. Font RL, Gamel JW. Adenoid cystic carcinoma of the lacrimal gland: a clinicopathologic study of 79 cases. In: Nicholson DH, ed. Ocular Pathology Update. New York, NY: Masson Publishing USA; 1980:277-283.
3. Kaplan MJ, Johns ME, Cantrell RW. Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg. 1986;95:165-170.
4. Jaffe N, Knapp J, Chuang VP, et al. Osteosarcoma: intra-arterial treatment of the primary tumor with c/s-diammine dichloroplatinum II (COP): angiographie, pathologic, and pharmacologie studies. Cancer. 1983:51:402-407.
5. Jatfe N, Robertson R, Ayala A, et al. Comparison of intra-arterial c/s-diammine dichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma. J Clin Oncol. 1985:3:1101 -1104.
6. Chuang VP, Benjamin R, Jaffe N, et al. Radiographie and angiographie changes in osteosarcoma after intraarterial chemotherapy. AJR Am J Roengenol. 1982; 139:1065-1069.
7. Stewart DJ, Wallace S, Feun L, et al. A phase I study of intracarotid artery infusion of c/s-diammine dichloroplatinum (II) in patients with recurrent malignant intracerebral tumors. Cancer Res. 1982;42:2059-2062.
8. Feun LG, Wallace S, Stewart DJ, et al. Intracarotid infusion of c/s-diamminine dichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer. 1984; 54:794-799.
9. Lehane DE, Bryan RN, Horowitz B, et al. Intraarterial c/s-platinum chemotherapy for patients with primary and metastatic brain tumors. Cancer Drug De/iv. 1983; 1:69-77.
10. Madajewicz S, Chowhan N, Iliya A, et al. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors. Cancer. 1991;67:28442849.
11. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group Trial. JClin Oncol. 1989:7:1646-1654.
12. Chang AE, Schneider PD, Sugarbaker PH. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver métastases. Ann Surg. 1987;206:685-693.
13. Kajanti M, Rissanen P, Virkkunen P, et al. Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma: a phase II study. Cancer. 1986;58: 2386-2388.
14. Pratt RMM, Betteridge TJ, Dixon P. Regional arterial cytotoxic perfusion combined with radical operation in breast cancer. BrJSurg. 1963:50:833-837.
15. Stephens FO. Intraarterial induction chemotherapy in locally advanced stage III breast cancer. Cancer. 1990:66:645-650.
16. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP. The regional treatment of liver métastases from breast cancer. J Surg Oncol. 1994;55:26-31.
17. Stephens FO, Harker GJ, Créa P. The intraarterial infusion of chemotherapeutic agents as basal treatment of cancer: evidence of increased drug activity in regionally infused tissues. AustNZJSurg. 1980:50:597-602.
18. Lee DA, Campbell RJ, Waller RR, llstrup DM. A clinicopathologic study of primary adenoid cystic carcinoma of the lacrimal gland. Ophthalmology. 1985;92: 128-134.
19. Forrest AW. Pathologic criteria for effective management of epithelial lacrimal gland tumors. Am JOphthalmol. 1971;71(suppl 1):178-192.
20. Wright JE, Rose GE, Garner A. Primary malignant neoplasms of the lacrimal gland. Br J Ophthalmol. 1992:76:401-407.
21. Henderson JW. Adenoid cystic carcinoma of the lacrimal gland: is there a cure? Trans Am Ophthalmol Soc. 1987;85:312-319.
22. Ni C, Cheng SC, Dryja TP, Cheng TY. Lacrimal gland tumors: a clinicopathological analysis of 160 cases. Int Ophthalmol Clin. 1982:22:99-120.
23. Sessions RB, Lehane DE, Smith RJH, Bryan RN, Suen JY. Intra-arterial cisplatin treatment of adenoid cystic carcinoma. Arch Otolaryngol. 1982;108:221-224.
24. Stephens FO, Harker GJS. The use of intra-arterial chemotherapy for treatment of malignant skin neoplasms. Australas J Dermatol. 1979:20:99-107.
25. Stephens FO. Induction chemotherapy using intraarterial infusion. Cancer Treat Pes. 1991:55:161 -170.
26. Stephens FO, Johnson AW, Créa P. Preoperative 'basal' chemotherapy in the management of cancer of the stomach. Med JAust. 1984;140:143-147.
27. Tsujino S, Ono Y, Ito T, et al. Semi selective intraarterial COMPA chemotherapy for invasive bladder cancer. Reg Cancer Treat. 1993:6:209-212.
28. Lee YY, Wallace S, Dimery I, Goepfert H. Intraarterial chemotherapy of head and neck tumors. AJNR Am J Neuroradiol. 1986:7:343-348.
29. Arcangeli G, Nervi C, Righini R, etal. Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. RadiotherOncol. 1983:1:101-107.
30. Stephens FO, Harker GJ, Hambly CK. Treatment of advanced cancers of the lower lip: the use of intraarterial or intravenous chemotherapy as basal treatment. Cancer. 1981:48:1309-1314.
31. Stephens FO, Kalnins IK, Harker GJ, Créa P, Smith ER. Intra-arterial infusion chemotherapy in the treatment of advanced squamous carcinoma of the tongue and floor of the mouth. Surg Gynecol Obstet. 1981:152:816-818.
32. Chauvel P, Lefebvre B, Luboinski B, et al. A multicentric study of the GETTEC about 408 clinically complete responses after neoadjuvant chemotherapy for head and neck carcinomas. In: Banzet P, Holland JF, Khayat D, Weil M, eds. Cancer Treatment: An Update. New York, NY: Springer-Verlag; 1994:291-294.
33. Stephens FO. Induction (neo-adjuvant) chemotherapy: systemic and arterial delivery techniques and their clinical applications. AustNZJ Surg. 1995:65:699707.
34. Suen JY, Johns ME. Chemotherapy for salivary gland cancer. Laryngoscope. 1982; 92:235-239.
35. Schramm VL Jr, Srodes C, Myers EN. Cisplatin therapy for adenoid cystic carcinoma. Arch Otolaryngol. 1981:107:739-741.
36. Tsukuda M, Kokatsu T, Ito K, Mochimatsu I, Kubota A, Sawaki S. Chemotherapy for recurrent adeno- and adenocystic carcinomas in the head and neck. J Cancer Res Clin Oncol. 1993:119:756-758.
37. Venook AP, Tseng A Jr, Meyers FJ, et al. Cisplatin, doxorubicin, and 5fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. JClin Oncol. 1987:5:951-955.
38. Margo CE, Murtagh FR. Ocular and orbital toxicity after intracarotid cisplatin therapy. Am J Ophthalmol. 1993;116:508-509.
39. Maise K, Walker RW, Gargan R, VictorJD. Intra-arterial cisplatin-associated optic and otic toxicity. Arch Neurol. 1992:49:83-86.
40. Shimamura Y, Chikama M, Tanimoto T, Kawakami Y, Tsutsumi A. Optic nerve degeneration caused by supraophthalmic carotid artery infusion with cisplatin and ACNU: case report. JNeumsurg. 1990;72:285-288.
41. Kupersmith MJ, Seiple WH, Holopigian K, Noble K, Hiesiger E, Warren F. Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine. Am J Ophthalmol. 1992:113:435-438.
42. Gamel JW, Font RL. Adenoid cystic carcinoma of the lacrimal gland: the clinical significance of a basaloid histologie pattern. Hum Pathol. 1982;13:219-225.